CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

REVA Medical annonce le succès de la démonstration en direct de MOTIV® et la publication des derniers résultats de l'essai BTK lors du congrès VIVA26

ConferencepositiveMOTIV®Positive
AI Analysis

Summary

REVA Medical presented successful live case demonstration of MOTIV® stent for below-the-knee revascularization at VIVA26 conference, with recent trial results showing higher efficacy rates compared to balloon angioplasty.

Clinical Trial Data

Primary Endpoint

Met

Outcome Details

Live case demonstration of successful below-the-knee revascularization using MOTIV® stents; trial results showing higher efficacy rates with MOTIV compared to balloon angioplasty

Importance:5/10
Sentiment:
0.70
medical devicescardiovascularclinical dataconference presentationvascular intervention
Related Companies

Read the original article

Published by PR Newswire Biotech on October 7, 2026 11:15 AM

Read Original